Close Menu

NEW YORK (GenomeWeb) – Bio-Techne this week reported that its revenue for the second quarter rose 17 percent year over year to $154.2 million from $131.8 million, exceeding the average analyst estimate of $146.3 million.

Revenues from the firm's diagnostics business segment fell 4 percent to $23.4 million from $24.3 million in the prior-year quarter. Sales volume in the quarter was negatively affected by continued "push-outs” of orders by original equipment manufacturers "in a very cost-conscious diagnostics industry," the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.